Sarcopenia is associated with worse surgical complications but not relapse-free survival and overall survival in patients with retroperitoneal liposarcoma

被引:2
|
作者
Zhao, Mingkun [1 ]
Lv, Minzhi [2 ]
Fang, Yuan [1 ]
Zhuang, Aobo [1 ,3 ]
Wu, Qian [1 ]
Tong, Hanxing [3 ]
Lu, Weiqi [3 ]
Zhang, Yong [3 ]
机构
[1] Fudan Univ, Shanghai Publ Hlth Clin Ctr, Dept Gen Surg, Shanghai, Peoples R China
[2] Fudan Univ, Zhongshan Hosp, Dept Biostat, Shanghai, Peoples R China
[3] Fudan Univ, Zhongshan Hosp, Dept Gen Surg, Shanghai, Peoples R China
基金
中国国家自然科学基金;
关键词
Retroperitoneal liposarcoma; Sarcopenia; Surgery complication; Relapse-free survival; Overall survival; SERUM CREATININE; RESECTION; SARCOMA; RECURRENCE; MORTALITY; PREDICTS; OUTCOMES; ALBUMIN; TISSUE; VOLUME;
D O I
10.1186/s12957-022-02846-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: This investigation aimed to explore the relationship between sarcopenia and severe postoperative complications, relapse-free survival (RFS), and overall survival (OS) in patients with retroperitoneal liposarcoma (RLPS).Material and methods: This retrospective study included 72 RLPS patients (47 men, 25 women; mean age, 57.49 years, SD 10.92) who had abdominal CT exams. Clinical information was recorded, including RLPS characteristics (histologic subtypes, grade, size), laboratory assessment (ALB, PALB, A/G, Hb, SCr), relapse-free survival, overall survival, and postoperative complications. The relationships between those variables and RFS and OS were analyzed using Cox proportional hazard models.Results: There were 8 severe postoperative complications (Clavien-Dindo grade > 2). The chi-square test showed sarcopenia was associated with severe postoperative complications (P = 0.011). In multivariate analysis, sarcopenia was not associated with relapse-free survival (P = 0.574) and overall survival (P = 0.578).Conclusions: Sarcopenia predicts worse surgical complications but does not affect relapse-free survival and overall survival.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Black race is associated with worse distant relapse-free survival in breast cancer patients treated with neoadjuvant compared to adjuvant systemic chemotherapy
    Pastoriza, Jessica M.
    Karagiannis, George S.
    Xue, Xionan
    Lin, Juan
    Condeelis, John S.
    Sparanno, Joseph A.
    Rohan, Thomas E.
    Oktay, Maja H.
    CANCER RESEARCH, 2018, 78 (04)
  • [22] Postoperative Complications in Patients With Rectal Cancer Are Associated With Delays in Chemotherapy That Lead to Worse Disease-free and Overall Survival
    Tevis, Sarah E.
    Kohlnhofer, Brittney M.
    Stringfield, Sarah
    Foley, Eugene F.
    Harms, Bruce A.
    Heise, Charles P.
    Kennedy, Gregory D.
    DISEASES OF THE COLON & RECTUM, 2013, 56 (12) : 1339 - 1348
  • [23] Stromal expression of cancer-associated fibroblast-related molecules, versican and lumican, is strongly associated with worse relapse-free and overall survival times in patients with esophageal squamous cell carcinoma
    Yamauchi, Naoto
    Kanke, Yasuyuki
    Saito, Katsuharu
    Okayama, Hirokazu
    Yamada, Shoki
    Nakajima, Shotaro
    Endo, Eisei
    Kase, Koji
    Yamada, Leo
    Nakano, Hiroshi
    Matsumoto, Takuro
    Hanayama, Hiroyuki
    Watanabe, Yohei
    Hayase, Suguru
    Saito, Motonobu
    Saze, Zenichiro
    Mimura, Kosaku
    Momma, Tomoyuki
    Oki, Shinji
    Hashimoto, Yuko
    Kono, Koji
    ONCOLOGY LETTERS, 2021, 21 (06)
  • [24] THE EFFECT OF ADJUVANT CHEMOTHERAPY ON RELAPSE-FREE SURVIVAL IN PATIENTS WITH OSTEOSARCOMA OF THE EXTREMITY
    LINK, MP
    GOORIN, AM
    MISER, AW
    GREEN, AA
    PRATT, CB
    BELASCO, JB
    PRITCHARD, J
    MALPAS, JS
    BAKER, AR
    KIRKPATRICK, JA
    AYALA, AG
    SHUSTER, JJ
    ABELSON, HT
    SIMONE, JV
    VIETTI, TJ
    NEW ENGLAND JOURNAL OF MEDICINE, 1986, 314 (25): : 1600 - 1606
  • [25] Occupational risk factors for relapse-free survival in bladder cancer patients
    Selinski, Silvia
    Buerger, Hannah
    Blaszkewicz, Meinolf
    Otto, Thomas
    Volkert, Frank
    Moormann, Oliver
    Niedner, Hartmut
    Hengstler, Jan G.
    Golka, Klaus
    JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES, 2016, 79 (22-23): : 1136 - 1143
  • [26] Polygenic risk score and relapse-free survival in bladder cancer patients
    Buerger, H.
    Golka, K.
    Blaszkewicz, M.
    Hengstler, J. G.
    Selinski, S.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2015, 388 : S86 - S86
  • [27] Overall survival and post-spontaneous regression relapse-free survival of patients with lymphoproliferative disorders associated with rheumatoid arthritis: a multi-center retrospective cohort study
    Saito, Rintaro
    Tanaka, Masao
    Ito, Hiromu
    Kuramoto, Nobuo
    Fujii, Takao
    Saito, Shuntaro
    Kaneko, Yuko
    Nakano, Kazuhisa
    Saito, Kazuyoshi
    Takada, Hideto
    Sugimoto, Naoki
    Sasaki, Sho
    Harigai, Masayoshi
    Suzuki, Yasuo
    MODERN RHEUMATOLOGY, 2022, 32 (01) : 50 - 58
  • [28] Development of a clinical scoring model to predict the overall and relapse-free survival of patients with hepatocellular carcinoma following a hepatectomy
    Deng, Wanyu
    Chen, Fu
    Li, Yuanxiang
    Xu, Leibo
    MOLECULAR AND CLINICAL ONCOLOGY, 2023, 19 (05)
  • [29] Black race is associated with worse distant relapse-free survival in breast cancer patients treated with neoadjuvant compared to adjuvant systemic chemotherapy.
    Pastoriza, Jessica M.
    Karagiannis, George S.
    Xue, Xiaonan
    Lin, Juan
    Condeelis, John S.
    Sparano, Joseph A.
    Rohan, Thomas E.
    Oktay, Maja H.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2018, 27 (07) : 102 - 103
  • [30] Dendritic Cell Therapy prolongs relapse-free Survival
    Krome, Susanne
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2025, 63 (02): : 120 - 120